CRP and obesity due to melanocortin 4 receptor deficiency: Moreover, the prevalence of elevated AGP (26.1% vs. 7.9%, p < 0.0001) and CRP (58.5% vs. 15.3%, p < 0.0001) was higher in obese women compared to women without obesity.